Jefferies Financial Group upgraded shares of ELEKTA AB/ADR (OTCMKTS:EKTAY) from an underperform rating to a hold rating in a research report report published on Tuesday morning, The Fly reports. Jefferies Financial Group also issued estimates for ELEKTA AB/ADR’s FY2020 earnings at $0.43 EPS, FY2021 earnings at $0.52 EPS, FY2022 earnings at $0.60 EPS and FY2023 earnings at $0.66 EPS.
A number of other equities analysts have also commented on EKTAY. ValuEngine lowered Woodward, Inc.Common Stock from a buy rating to a hold rating in a research note on Tuesday, April 9th. Zacks Investment Research upgraded Global Ship Lease from a hold rating to a strong-buy rating and set a $7.75 price objective on the stock in a research note on Monday, June 3rd.
ELEKTA AB/ADR stock opened at $13.80 on Tuesday. The company has a quick ratio of 0.93, a current ratio of 1.18 and a debt-to-equity ratio of 0.62. The business has a 50-day simple moving average of $13.74. The company has a market capitalization of $5.01 billion, a price-to-earnings ratio of 39.43, a PEG ratio of 2.68 and a beta of 0.45. ELEKTA AB/ADR has a 52 week low of $10.95 and a 52 week high of $14.61.
Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.
Featured Article: Why Net Income is Important to Investors
Receive News & Ratings for ELEKTA AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEKTA AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.